Respiratory syncytial virus ... to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays); however, rapid antigen-detection tests ...

The highly contagious respiratory syncytial virus (RSV) typically causes mild illness, but it can lead to severe respiratory complications, particularly for at-risk individuals. Drawing on local ...

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Our primary goal was to develop two real-time multiplex polymerase chain reaction (PCR) assays for simultaneous detection of ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Molecular testing, such as polymerase chain reaction (PCR ... and speed of disease detection. These advancements are not only essential for identifying common respiratory pathogens like influenza and ...

Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

What if infections of respiratory syncytial virus, known as R.S.V., peak at unusual levels, as they did in the 2022-23 season? What if the new strain of mpox, which is especially virulent ...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

The microbiologic confirmation of RSV infection is based on detecting the virus in a sample of wash or a swab obtained from the nasopharyngeal cavity. A variety of laboratory techniques can be ...